Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,473 | 63 | 93.6% |
| Education | $99.99 | 1 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| OPKO Pharmaceuticals, LLC | $275.09 | 15 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $260.56 | 11 | $0 (2022) |
| W. L. Gore & Associates, Inc. | $171.61 | 1 | $0 (2017) |
| Baxter Healthcare | $120.14 | 3 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $100.89 | 1 | $0 (2017) |
| Horizon Therapeutics plc | $92.42 | 4 | $0 (2023) |
| Relypsa, Inc. | $82.15 | 6 | $0 (2020) |
| Mallinckrodt Hospital Products Inc. | $71.38 | 3 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $70.20 | 3 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $66.57 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $64.87 | 3 | Mallinckrodt Hospital Products Inc. ($23.97) |
| 2023 | $159.67 | 7 | Horizon Therapeutics plc ($51.73) |
| 2022 | $341.28 | 14 | Baxter Healthcare ($101.32) |
| 2021 | $231.84 | 8 | AstraZeneca Pharmaceuticals LP ($119.61) |
| 2020 | $165.50 | 9 | OPKO Pharmaceuticals, LLC ($53.76) |
| 2019 | $207.33 | 12 | AstraZeneca Pharmaceuticals LP ($72.85) |
| 2018 | $93.82 | 6 | OPKO Pharmaceuticals, LLC ($43.46) |
| 2017 | $309.04 | 5 | W. L. Gore & Associates, Inc. ($171.61) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/25/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Inflammation/Rare Disease | ||||||
| 02/28/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: IMMUNOLOGY | ||||||
| 02/22/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Phosphate binder for ESRD | ||||||
| 12/14/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $25.24 | General |
| Category: KRYSTEXXA | ||||||
| 12/07/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $26.49 | General |
| Category: KRYSTEXXA | ||||||
| 11/09/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: IMMUNOLOGY | ||||||
| 08/31/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: INTERNAL MEDICINE | ||||||
| 06/15/2023 | Fresenius USA Marketing, Inc. | Velphoro (Drug), KORSUVA | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Phosphate binder for ESRD | ||||||
| 06/01/2023 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $27.79 | General |
| 11/01/2022 | Baxter Healthcare | Renal - PD (Device) | Food and Beverage | In-kind items and services | $62.86 | General |
| Category: Renal | ||||||
| 09/19/2022 | Baxter Healthcare | Renal - PD (Device) | Food and Beverage | In-kind items and services | $38.46 | General |
| Category: Renal | ||||||
| 09/15/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.67 | General |
| Category: KRYSTEXXA | ||||||
| 08/25/2022 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: KRYSTEXXA | ||||||
| 06/23/2022 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Diabetes | ||||||
| 06/16/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Cardio-renal | ||||||
| 05/19/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/12/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Cardio-renal | ||||||
| 05/05/2022 | Amgen Inc. | Tavneos (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Not Applicable | ||||||
| 02/25/2022 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: NEPHROLOGY | ||||||
| 02/11/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Cardio-renal | ||||||
| 01/20/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/13/2022 | GENZYME CORPORATION | FABRAZYME (Biological) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Genetic Disease | ||||||
| 01/06/2022 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 12/03/2021 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 588 | 1,348 | $303,536 | $180,086 |
| 2022 | 9 | 658 | 1,547 | $349,266 | $208,471 |
| 2021 | 9 | 734 | 1,652 | $376,544 | $230,813 |
| 2020 | 9 | 815 | 1,838 | $435,734 | $227,755 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 43 | 303 | $136,350 | $84,009 | 61.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 257 | 486 | $77,760 | $44,126 | 56.7% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 41 | 77 | $26,950 | $17,918 | 66.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 66 | 203 | $22,330 | $13,005 | 58.2% |
| 90937 | Hemodialysis procedure requiring repeated evaluation | Facility | 2023 | 25 | 88 | $13,640 | $7,197 | 52.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 68 | 88 | $13,376 | $5,987 | 44.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 83 | $9,130 | $5,506 | 60.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $4,000 | $2,339 | 58.5% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 52 | 355 | $159,750 | $99,809 | 62.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 297 | 550 | $88,000 | $51,106 | 58.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 51 | 77 | $26,950 | $18,274 | 67.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 65 | 260 | $28,600 | $14,587 | 51.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 81 | 108 | $16,416 | $8,706 | 53.0% |
| 90937 | Hemodialysis procedure requiring repeated evaluation | Facility | 2022 | 24 | 92 | $14,260 | $7,599 | 53.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 54 | $5,940 | $2,895 | 48.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 23 | 23 | $4,600 | $2,812 | 61.1% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 11 | 11 | $2,750 | $1,770 | 64.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 11 | 17 | $2,000 | $913.73 | 45.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 56 | 432 | $194,400 | $125,185 | 64.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 351 | 621 | $99,360 | $59,506 | 59.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 78 | 253 | $27,830 | $14,565 | 52.3% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 90 | 107 | $16,264 | $8,865 | 54.5% |
| 90937 | Hemodialysis procedure with repeated evaluations | Facility | 2021 | 28 | 95 | $14,725 | $7,654 | 52.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 62 | 70 | $7,700 | $5,132 | 66.6% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 16 | 20 | $7,000 | $4,868 | 69.5% |
About Dr. Imran Rashid, M.D
Dr. Imran Rashid, M.D is a Specialist healthcare provider based in Titusville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2005. The National Provider Identifier (NPI) number assigned to this provider is 1912900325.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Imran Rashid, M.D has received a total of $1,573 in payments from pharmaceutical and medical device companies, with $64.87 received in 2024. These payments were reported across 64 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,473).
As a Medicare-enrolled provider, Rashid has provided services to 2,795 Medicare beneficiaries, totaling 6,385 services with total Medicare billing of $847,125. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Nephrology, Internal Medicine
- Location Titusville, FL
- Active Since 05/31/2005
- Last Updated 02/24/2011
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1912900325
Products in Payments
- VIABAHN Endoprosthesis with Heparin Bioactive Surface (Device) $171.61
- RAYALDEE (Drug) $171.01
- Renal - PD (Device) $120.14
- KRYSTEXXA (Biological) $112.19
- LOKELMA (Drug) $111.20
- Rayaldee (Drug) $104.08
- ENTRESTO (Drug) $100.89
- BRILINTA (Drug) $99.99
- Veltassa (Drug) $82.15
- ACTHAR (Biological) $71.38
- Kerendia (Drug) $70.20
- JYNARQUE (Drug) $66.57
- Velphoro (Drug) $39.49
- FARXIGA (Drug) $32.72
- Crysvita (Drug) $23.75
- TRELEGY ELLIPTA (Drug) $19.38
- GVOKE PFS (Drug) $18.59
- INJECTAFER (Drug) $17.80
- NATPARA (Drug) $16.89
- SYMBICORT (Drug) $16.65
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Titusville
Dr. Robert Mcshane, M.d, M.D
Specialist — Payments: $4,872
Dr. Sachin Shenoy, Md, MD
Specialist — Payments: $2,259
Dr. Justo Gonzalez, M.d, M.D
Specialist — Payments: $1,665
Dr. Joseph Rojas, M.d, M.D
Specialist — Payments: $1,120
Dr. Aluino Ochoa, M.d, M.D
Specialist — Payments: $889.65
Dr. Karin Ochoa, Md, MD
Specialist — Payments: $593.60